Cover Image

TARIS BioMedical, Inc.:產品平台分析

TARIS BioMedical, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 256105
出版日期 內容資訊 英文 18 Pages
Back to Top
TARIS BioMedical, Inc.:產品平台分析 TARIS BioMedical, Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 18 Pages



TARIS Biomedical, Inc.是活用藥物遞送技術以開發膀胱疾病治療法的製藥公司。正在開發以一般最低侵襲性泌尿器科學性來將治療藥遞送至目標組織內的治療法。吾時也綜合滲透壓、形狀記憶、植入保持等三個技術。該公司同時也提供各種膀胱疾病治療藥。

本報告提供TARIS BioMedical, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

TARIS BioMedical, Inc.的基本資料

  • TARIS BioMedical, Inc.概要
  • 主要資訊
  • 企業資料

TARIS BioMedical, Inc.:R&D概要

  • 主要的治療範圍

TARIS BioMedical, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

TARIS BioMedical, Inc.:開發中產品概況

  • 臨床實驗階段有的開發中產品
    • 第二階段有的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

TARIS BioMedical, Inc.:藥物簡介

  • lidocaine
  • NMIBC Program
  • TD-210
  • TD-302

TARIS BioMedical, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

TARIS BioMedical, Inc.:最近的開發平台趨勢

TARIS BioMedical, Inc.:暫停中的計劃

TARIS BioMedical, Inc.:總公司和子公司的所在地



Product Code: GMDHC07389CDB


Global Markets Direct's, 'TARIS BioMedical, Inc. - Product Pipeline Review - 2015', provides an overview of the TARIS BioMedical, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of TARIS BioMedical, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


  • The report provides brief overview of TARIS BioMedical, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of TARIS BioMedical, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the TARIS BioMedical, Inc.'s pipeline products

Reasons to buy

  • Evaluate TARIS BioMedical, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of TARIS BioMedical, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the TARIS BioMedical, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of TARIS BioMedical, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of TARIS BioMedical, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of TARIS BioMedical, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • TARIS BioMedical, Inc. Snapshot
    • TARIS BioMedical, Inc. Overview
    • Key Information
    • Key Facts
  • TARIS BioMedical, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • TARIS BioMedical, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • TARIS BioMedical, Inc. - Pipeline Products Glance
    • TARIS BioMedical, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • TARIS BioMedical, Inc. - Drug Profiles
    • Drug for NMIBC
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TD-210
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TD-302
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • TARIS BioMedical, Inc. - Dormant Projects
  • TARIS BioMedical, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • TARIS BioMedical, Inc., Key Information
  • TARIS BioMedical, Inc., Key Facts
  • TARIS BioMedical, Inc. - Pipeline by Indication, 2015
  • TARIS BioMedical, Inc. - Pipeline by Stage of Development, 2015
  • TARIS BioMedical, Inc. - Monotherapy Products in Pipeline, 2015
  • TARIS BioMedical, Inc. - Out-Licensed Products in Pipeline, 2015
  • TARIS BioMedical, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • TARIS BioMedical, Inc. - Preclinical, 2015
  • TARIS BioMedical, Inc. - Dormant Developmental Projects,2015

List of Figures

  • TARIS BioMedical, Inc. - Pipeline by Top 10 Indication, 2015
Back to Top